TY - JOUR AU - Chen, W. AU - Zheng, R. AU - Baade, P. D. PY - 2016 DA - 2016// TI - Cancer statistics in China, 2015 JO - CA Cancer J Clin VL - 66 UR - https://doi.org/10.3322/caac.21338 DO - 10.3322/caac.21338 ID - Chen2016 ER - TY - JOUR AU - DeSantis, C. E. PY - 2014 DA - 2014// TI - Cancer treatment and survivorship statistics, 2014 JO - CA Cancer J Clin VL - 64 UR - https://doi.org/10.3322/caac.21235 DO - 10.3322/caac.21235 ID - DeSantis2014 ER - TY - JOUR AU - Mitsui, Y. AU - Yasumoto, H. AU - Arichi, N. AU - Honda, S. AU - Shiina, H. AU - Igawa, M. PY - 2012 DA - 2012// TI - Current chemotherapeutic strategies against bladder cancer JO - Int Urol Nephrol VL - 44 UR - https://doi.org/10.1007/s11255-011-0009-8 DO - 10.1007/s11255-011-0009-8 ID - Mitsui2012 ER - TY - JOUR AU - Mishra, S. AU - Murphy, L. C. AU - Nyomba, B. L. AU - Murphy, L. J. PY - 2005 DA - 2005// TI - Prohibitin: a potential target for new therapeutics JO - Trends Mol Med VL - 11 UR - https://doi.org/10.1016/j.molmed.2005.02.004 DO - 10.1016/j.molmed.2005.02.004 ID - Mishra2005 ER - TY - JOUR AU - McClung, J. K. PY - 1989 DA - 1989// TI - Isolation of a cDNA that hybrid selects antiproliferative mRNA from rat liver JO - Biochem Biophys Res Commun VL - 164 UR - https://doi.org/10.1016/0006-291X(89)91813-5 DO - 10.1016/0006-291X(89)91813-5 ID - McClung1989 ER - TY - JOUR AU - Koushyar, S. AU - Jiang, W. G. AU - Dart, D. A. PY - 2015 DA - 2015// TI - Unveiling the potential of prohibitin in cancer JO - Cancer Lett VL - 369 UR - https://doi.org/10.1016/j.canlet.2015.09.012 DO - 10.1016/j.canlet.2015.09.012 ID - Koushyar2015 ER - TY - JOUR AU - Peng, Y. T. AU - Chen, P. AU - Ouyang, R. Y. AU - Song, L. PY - 2015 DA - 2015// TI - Multifaceted role of prohibitin in cell survival and apoptosis JO - Apoptosis VL - 20 UR - https://doi.org/10.1007/s10495-015-1143-z DO - 10.1007/s10495-015-1143-z ID - Peng2015 ER - TY - JOUR AU - Gamble, S. C. PY - 2004 DA - 2004// TI - Androgens target prohibitin to regulate proliferation of prostate cancer cells JO - Oncogene VL - 23 UR - https://doi.org/10.1038/sj.onc.1207444 DO - 10.1038/sj.onc.1207444 ID - Gamble2004 ER - TY - JOUR AU - Canevari, R. A. PY - 2016 DA - 2016// TI - Identification of novel biomarkers associated with poor patient outcomes in invasive breast carcinoma JO - Tumour Biol VL - 37 UR - https://doi.org/10.1007/s13277-016-5133-8 DO - 10.1007/s13277-016-5133-8 ID - Canevari2016 ER - TY - JOUR AU - Kang, X. PY - 2008 DA - 2008// TI - Prohibitin: a potential biomarker for tissue-based detection of gastric cancer JO - J Gastroenterol VL - 43 UR - https://doi.org/10.1007/s00535-008-2208-3 DO - 10.1007/s00535-008-2208-3 ID - Kang2008 ER - TY - JOUR AU - Jiang, L. AU - Dong, P. AU - Zhang, Z. AU - Li, C. AU - Li, Y. AU - Liao, Y. AU - Li, X. AU - Wu, Z. AU - Guo, S. AU - Mai, S. PY - 2015 DA - 2015// TI - Akt phosphorylates Prohibitin 1 to mediate its mitochondrial localization and promote proliferation of bladder cancer cells JO - Cell Death Dis VL - 6 UR - https://doi.org/10.1038/cddis.2015.40 DO - 10.1038/cddis.2015.40 ID - Jiang2015 ER - TY - JOUR AU - Polier, G. PY - 2012 DA - 2012// TI - The natural anticancer compounds rocaglamides inhibit the Raf-MEK-ERK pathway by targeting prohibitin 1 and 2 JO - Chem Biol VL - 19 UR - https://doi.org/10.1016/j.chembiol.2012.07.012 DO - 10.1016/j.chembiol.2012.07.012 ID - Polier2012 ER - TY - JOUR AU - Qureshi, R. AU - Yildirim, O. AU - Gasser, A. AU - Basmadjian, C. AU - Zhao, Q. AU - Wilmet, J. P. AU - Désaubry, L. AU - Nebigil, C. G. PY - 2015 DA - 2015// TI - FL3, a synthetic Flavagline and ligand of Prohibitins, protects cardiomyocytes via STAT3 from doxorubicin toxicity JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0141826 DO - 10.1371/journal.pone.0141826 ID - Qureshi2015 ER - TY - JOUR AU - Basmadjian, C. AU - Thuaud, F. AU - Ribeiro, N. AU - Désaubry, L. PY - 2013 DA - 2013// TI - Flavaglines: potent anticancer drugs that target prohibitins and the helicase eIF4A JO - Future Med Chem VL - 5 UR - https://doi.org/10.4155/fmc.13.177 DO - 10.4155/fmc.13.177 ID - Basmadjian2013 ER - TY - JOUR AU - Kim, S. AU - Salim, A. A. AU - Swanson, S. M. AU - Kinghorn, A. D. PY - 2006 DA - 2006// TI - Potential of cyclopenta[b]benzofurans from Aglaia species in cancer chemotherapy JO - Anti Cancer Agents Med Chem VL - 6 UR - https://doi.org/10.2174/187152006777698123 DO - 10.2174/187152006777698123 ID - Kim2006 ER - TY - JOUR AU - Thuaud, F. AU - Bernard, Y. AU - Türkeri, G. AU - Dirr, R. AU - Aubert, G. AU - Cresteil, T. AU - Baguet, A. AU - Tomasetto, C. AU - Svitkin, Y. AU - Sonenberg, N. PY - 2009 DA - 2009// TI - Synthetic analogue of rocaglaol displays a potent and selective cytotoxicity in cancer cells: involvement of apoptosis inducing factor and caspase-12 JO - J Med Chem VL - 52 UR - https://doi.org/10.1021/jm900365v DO - 10.1021/jm900365v ID - Thuaud2009 ER - TY - JOUR AU - McClung, J. K. AU - Jupe, E. R. AU - Liu, X. T. AU - Dell'Orco, R. T. PY - 1995 DA - 1995// TI - Prohibitin: potential role in senescence, development, and tumor suppression JO - Exp Gerontol VL - 30 UR - https://doi.org/10.1016/0531-5565(94)00069-7 DO - 10.1016/0531-5565(94)00069-7 ID - McClung1995 ER - TY - JOUR AU - Thuaud, F. AU - Ribeiro, N. AU - Nebigil, C. G. AU - Désaubry, L. PY - 2013 DA - 2013// TI - Prohibitin ligands in cell death and survival: mode of action and therapeutic potential JO - Chem Biol VL - 20 UR - https://doi.org/10.1016/j.chembiol.2013.02.006 DO - 10.1016/j.chembiol.2013.02.006 ID - Thuaud2013 ER - TY - JOUR AU - Zhou, T. B. AU - Qin, Y. H. PY - 2013 DA - 2013// TI - Signaling pathways of prohibitin and its role in diseases JO - J Recept Signal Transduct Res VL - 33 UR - https://doi.org/10.3109/10799893.2012.752006 DO - 10.3109/10799893.2012.752006 ID - Zhou2013 ER - TY - JOUR AU - Ande, S. R. AU - Mishra, S. PY - 2009 DA - 2009// TI - Prohibitin interacts with phosphatidylinositol 3,4,5-triphosphate (PIP3) and modulates insulin signaling JO - Biochem Biophys Res Commun VL - 390 UR - https://doi.org/10.1016/j.bbrc.2009.10.101 DO - 10.1016/j.bbrc.2009.10.101 ID - Ande2009 ER - TY - JOUR AU - Malumbres, M. AU - Barbacid, M. PY - 2009 DA - 2009// TI - Cell cycle, CDKs and cancer: a changing paradigm JO - Nat Rev Cancer VL - 9 UR - https://doi.org/10.1038/nrc2602 DO - 10.1038/nrc2602 ID - Malumbres2009 ER - TY - JOUR AU - Chen, R. Y. AU - Fan, Y. M. AU - Zhang, Q. AU - Liu, S. AU - Li, Q. AU - Ke, G. L. AU - Li, C. AU - You, Z. PY - 2015 DA - 2015// TI - Estradiol inhibits Th17 cell differentiation through inhibition of RORγT transcription by recruiting the ERα/REA complex to estrogen response elements of the RORγT promoter JO - J Immunol VL - 194 UR - https://doi.org/10.4049/jimmunol.1400806 DO - 10.4049/jimmunol.1400806 ID - Chen2015 ER - TY - JOUR AU - Dai, L. AU - Liu, Y. AU - Liu, J. AU - Wen, X. AU - Xu, Z. AU - Wang, Z. AU - Sun, H. AU - Tang, S. AU - Maguire, A. R. AU - Quan, J. PY - 2013 DA - 2013// TI - A novel cyclinE/cyclinA-CDK inhibitor targets p27(Kip1) degradation, cell cycle progression and cell survival: implications in cancer therapy JO - Cancer Lett VL - 333 UR - https://doi.org/10.1016/j.canlet.2013.01.025 DO - 10.1016/j.canlet.2013.01.025 ID - Dai2013 ER - TY - JOUR AU - Park, H. Y. AU - Kim, G. Y. AU - Moon, S. K. AU - Kim, W. J. AU - Yoo, Y. H. AU - Choi, Y. H. PY - 2014 DA - 2014// TI - Fucoidan inhibits the proliferation of human urinary bladder cancer T24 cells by blocking cell cycle progression and inducing apoptosis JO - Molecules VL - 19 UR - https://doi.org/10.3390/molecules19055981 DO - 10.3390/molecules19055981 ID - Park2014 ER - TY - STD TI - Cell Cycle of PCR Arrays in QIAGEN Website. SABiosciences Corporation, Maryland, US. 2017. https://www.sabiosciences.com/cn/shop/pcr/primer-sets/rt2-profiler-pcr-arrays/?catno=PAHS-020Z#geneglobe. Accessed 21 Aug 2017. UR - https://www.sabiosciences.com/cn/shop/pcr/primer-sets/rt2-profiler-pcr-arrays/?catno=PAHS-020Z#geneglobe ID - ref25 ER - TY - JOUR AU - Wang, X. W. PY - 1999 DA - 1999// TI - GADD45 induction of a G2/M cell cycle checkpoint JO - Proc Natl Acad Sci U S A VL - 96 UR - https://doi.org/10.1073/pnas.96.7.3706 DO - 10.1073/pnas.96.7.3706 ID - Wang1999 ER - TY - JOUR AU - Ande, S. R. AU - Nguyen, K. H. AU - Nyomba, B. L. AU - Mishra, S. PY - 2016 DA - 2016// TI - Prohibitin in adipose and immune functions JO - Trends Endocrinol Metab VL - 27 UR - https://doi.org/10.1016/j.tem.2016.05.003 DO - 10.1016/j.tem.2016.05.003 ID - Ande2016 ER - TY - JOUR AU - Chowdhury, I. AU - Thomas, K. AU - Thompson, W. E. PY - 2016 DA - 2016// TI - Prohibitin( PHB) roles in granulosa cell physiology JO - Cell Tissue Res VL - 363 UR - https://doi.org/10.1007/s00441-015-2302-9 DO - 10.1007/s00441-015-2302-9 ID - Chowdhury2016 ER - TY - JOUR AU - Li, L. AU - Guo, J. D. AU - Wang, H. D. AU - Shi, Y. M. AU - Yuan, Y. L. AU - Hou, S. X. PY - 2015 DA - 2015// TI - Prohibitin 1 gene delivery promotes functional recovery in rats with spinal cord injury JO - Neuroscience VL - 286 UR - https://doi.org/10.1016/j.neuroscience.2014.11.037 DO - 10.1016/j.neuroscience.2014.11.037 ID - Li2015 ER - TY - JOUR AU - Chowdhury, I. AU - Thompson, W. E. AU - Thomas, K. PY - 2014 DA - 2014// TI - Prohibitins role in cellular survival through Ras-Raf-MEK-ERK pathway JO - J Cell Physiol VL - 229 UR - https://doi.org/10.1002/jcp.24531 DO - 10.1002/jcp.24531 ID - Chowdhury2014 ER - TY - JOUR AU - Luan, Z. AU - He, Y. AU - Alattar, M. AU - Chen, Z. AU - He, F. PY - 2014 DA - 2014// TI - Targeting the prohibitin scaffold-CRAF kinase interaction in RAS-ERK-driven pancreatic ductal adenocarcinoma JO - Mol Cancer VL - 13 UR - https://doi.org/10.1186/1476-4598-13-38 DO - 10.1186/1476-4598-13-38 ID - Luan2014 ER - TY - STD TI - Yurugi H, Marini F, Weber C, David K, Zhao Q, Binder H, Désaubry L, Rajalingam K. Targeting prohibitins with chemical ligands inhibits KRAS-mediated lung tumours. Oncogene. 2017; ID - ref32 ER - TY - JOUR AU - Ribeiro, N. PY - 2012 DA - 2012// TI - Flavaglines as potent anticancer and cytoprotective agents JO - J Med Chem VL - 55 UR - https://doi.org/10.1021/jm301201z DO - 10.1021/jm301201z ID - Ribeiro2012 ER - TY - JOUR AU - Callahan, K. P. PY - 2014 DA - 2014// TI - Flavaglines target primitive leukemia cells and enhance anti-leukemia drug activity JO - Leukemia VL - 28 UR - https://doi.org/10.1038/leu.2014.93 DO - 10.1038/leu.2014.93 ID - Callahan2014 ER - TY - STD TI - Bahrami A, et al. The potential value of the PI3K/Akt/mTOR signaling pathway for assessing prognosis in cervical cancer and as a target for therapy. J Cell Biochem. 2017; ID - ref35 ER - TY - STD TI - Nan Y, et al. Combinatorial therapy with adenoviral-mediated PTEN and a PI3K inhibitor suppresses malignant glioma cell growth in vitro and in vivo by regulating the PI3K/AKT signaling pathway. J Cancer Res Clin Oncol. 2017; ID - ref36 ER - TY - JOUR AU - Lien, E. C. AU - Dibble, C. C. AU - Toker, A. PY - 2017 DA - 2017// TI - PI3K signaling in cancer: beyond AKT JO - Curr Opin Cell Biol VL - 45 UR - https://doi.org/10.1016/j.ceb.2017.02.007 DO - 10.1016/j.ceb.2017.02.007 ID - Lien2017 ER - TY - JOUR AU - Mayer, I. A. AU - Arteaga, C. L. PY - 2016 DA - 2016// TI - The PI3K/AKT pathway as a target for cancer treatment JO - Annu Rev Med VL - 67 UR - https://doi.org/10.1146/annurev-med-062913-051343 DO - 10.1146/annurev-med-062913-051343 ID - Mayer2016 ER - TY - JOUR AU - Han, E. K. AU - Mcgonigal, T. AU - Butler, C. AU - Giranda, V. L. AU - Luo, Y. PY - 2008 DA - 2008// TI - Characterization of Akt overexpression in MiaPaCa-2 cells: prohibitin is an Akt substrate both in vitro and in cells JO - Anticancer Res VL - 28 ID - Han2008 ER - TY - JOUR AU - Berger, K. H. AU - Yaffe, M. P. PY - 1998 DA - 1998// TI - Prohibitin family members interact genetically with mitochondrial inheritance components in Saccharomyces Cerevisiae JO - Mol Cell Biol VL - 18 UR - https://doi.org/10.1128/MCB.18.7.4043 DO - 10.1128/MCB.18.7.4043 ID - Berger1998 ER - TY - JOUR AU - Bogenhagen, D. F. AU - Wang, Y. AU - Shen, E. L. AU - Kobayashi, R. PY - 2003 DA - 2003// TI - Protein components of mitochondrial DNA nucleoids in higher eukaryotes JO - Mol Cell Proteomics VL - 2 UR - https://doi.org/10.1074/mcp.M300035-MCP200 DO - 10.1074/mcp.M300035-MCP200 ID - Bogenhagen2003 ER - TY - JOUR AU - Zhan, Q. PY - 1999 DA - 1999// TI - Association with Cdc2 and inhibition of Cdc2/cyclin B1 kinase activity by the p53-regulated protein Gadd45 JO - Oncogene VL - 18 UR - https://doi.org/10.1038/sj.onc.1202667 DO - 10.1038/sj.onc.1202667 ID - Zhan1999 ER - TY - JOUR AU - Malumbres, M. AU - Barbacid, M. PY - 2005 DA - 2005// TI - Mammalian cyclin-dependent kinases JO - Trends Biochem Sci VL - 30 UR - https://doi.org/10.1016/j.tibs.2005.09.005 DO - 10.1016/j.tibs.2005.09.005 ID - Malumbres2005 ER - TY - JOUR AU - Salvador, J. M. AU - Brown-Clay, J. D. AU - Fornace, A. J. PY - 2013 DA - 2013// TI - Gadd45 in stress signaling, cell cycle control, and apoptosis JO - Adv Exp Med Biol VL - 793 UR - https://doi.org/10.1007/978-1-4614-8289-5_1 DO - 10.1007/978-1-4614-8289-5_1 ID - Salvador2013 ER -